Click to view the full infographic
Access to medicine around the world is still a huge and disparate issue, most notably in developing countries. Here, GOLD tracks the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.
